Company intelligence / Profile preview

3i Bioscience Trust

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

3i Bioscience Investment Trust plc was a prominent UK-listed investment trust dedicated to the bioscience and healthcare sectors. Originally established in 1981 as Biotechnology Investments Limited (BIL) by Lord Rothschild, the trust was rebranded after 3i Group assumed management in 2000. It maintained a global portfolio of investments in biotechnology, pharmaceuticals, and medical technology, supporting companies from venture stages through to public listing. The trust was a key vehicle for institutional and retail investors to gain exposure to the life sciences sector until its voluntary liquidation in 2005.

Industry: Investors

Beyond the preview

Go deeper on 3i Bioscience Trust.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3i Bioscience Trust.

Explore the full profile